1Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989 246:1306～1309
2Terman BI, Carrion-ME, Kovacs-E, et al. Idetification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991 Sep6 (9): 1677～1683
3Borg JP, deLapeyriere-O; Noguchi-T; Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase.Oncogene 1995 Mar2; 10 (5): 973～984
4Galland F, karamysheva-A, Pebusque-MJ, et al. The FLT4 gene encodes a transmembrance tyrosine kinase related to the vascular endothelial growth factor recepotor. Oncogene 1993 May; 8 (5):1233～ 1240
5Nomura M, Yamagishi S, Harada S, et al. Possible Participation of autocrine and paracrine vascular endothelial growth factors in hypoxiainduced proliferation of endothelial cells and pericytes. J. Biol.Chem 1995 270 (47): 28316～28324
6Hashimot E, Ogita-T; Nakaoka-T, et al. Rapid indution of vascular endothelial growth factor expression by transcient ischemia in rat heart. AM. J. Physiol 1994 Nov; 267 (5pt2): H1948～1954
7Levy AP, Levy-NS; Wegner-s, et al. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol.Chem 1995 June2; 270 (22): 13333～13340
8Shima DT, Dentsch V, D'A more PA. Hypoxia induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS-Lett 1995 Aug 21; 370(3): 203～208
9Smith LEH, Kopchick JJ, Chen W, et al. Essential role of growth hormone in ischemia-indeced retinal neovascularization. Science 1997 276 (13): 1706～1708
10Soh EY, Sobhi SA, Wong MG, et al. Thyroid-Stimulation hormone promotes the secretion of vascular endothelial growth factor in thyriodcancer cell lines. Surgery 1996 Dec; 120 (6): 944～947
9[13]H Funatsu, H Yamashita, Y Nakanishi, et al. Angiotensin Ⅱ and vasualar endothelical growth factor in the vitreous fluid of patients with proliferatise diabetic retinopathy[J]. British jeurnal of ophthalmology, 2002,86(3):311.
10[15]W M Haddad, G Cossas, G Soubrane. Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration[J]. British journal of ophthalmology, 2002,86(6):663.
